Welcome to our dedicated page for Waterdrop American news (Ticker: WDH), a resource for investors and traders seeking the latest updates and insights on Waterdrop American stock.
Waterdrop Inc. reports recurring developments for its NYSE-listed American depositary shares and its technology platform for insurance and healthcare services. Company news centers on unaudited quarterly and fiscal results, insurance-related revenue, cash dividends, ADS repurchases, and annual Form 20-F reporting.
Operational updates also cover Waterdrop Medical Crowdfunding, including risk-control and donor-transparency systems, and the E-Find Platform, the company’s digital clinical trial solution for patient enrollment and drug-patient matching. Product and technology updates include insurance plan launches, data infrastructure, automated review tools, and medical knowledge graph applications.
Waterdrop (NYSE: WDH) will report unaudited fourth quarter and fiscal year 2025 results before U.S. markets open on March 25, 2026. Management will host an earnings conference call the same day at 8:00 AM ET (8:00 PM Beijing/Hong Kong).
Telephone dial-in numbers, interpretation lines, replay access through April 1, 2026, and a live/archived webcast on the company's investor relations site are provided for investors.
Waterdrop (NYSE: WDH) reported third-quarter 2025 unaudited results for the period ended Sept 30, 2025: net operating revenue RMB 974.9 million (+38.4% YoY) and net profit attributable to ordinary shareholders RMB 158.5 million (+60.1% YoY), marking the fifteenth consecutive profitable quarter.
Operating expenses fell to 39.6% of revenue, down 8.3 percentage points YoY. Since 2021, the company repurchased ~58.1 million ADSs through Nov 30, 2025. Insurance revenue grew to RMB 869.7 million (+44.8% YoY) with insurance operating profit RMB 176.4 million (+44% YoY). Medical crowdfunding raised RMB 71.2 billion for 3.61 million patients cumulatively.
Waterdrop (NYSE: WDH) reported unaudited Q3 2025 results on Dec 3, 2025: net operating revenue RMB974.9M (+38.4% YoY) and insurance-related income RMB869.7M (+44.8% YoY). Operating profit rose to RMB113.8M (+329.8% YoY) and net profit attributable to shareholders was RMB158.5M (+60.1% YoY). Cash position stood at RMB3,510.0M as of Sep 30, 2025. E-Find enrolled 13,282 patients cumulatively; medical crowdfunding facilitated RMB71.2B donated to 3.61M patients. Company repurchased ~58.1M ADSs for ~$113.4M through Nov 30, 2025.
Waterdrop (NYSE: WDH) won the Global Best Case Brands Award at the 3rd International Conference on Management Change and Sustainable Development on Dec 2, 2025, recognized from 100+ nominees for contributions to inclusive protection and case-based research.
The company highlights its AI and product milestones: ~RMB 300 million annual tech R&D since 2019, GuardianShuishou LLM filings and >100 AI patents, 214 pre-existing-condition insurance offerings in 2025, and Waterdrop Medical Crowdfunding which raised ~RMB 70 billion for 3.54 million patients as of Jun 2025.
Waterdrop (NYSE: WDH) will report its unaudited financial results for the third quarter ended September 30, 2025 before U.S. markets open on December 3, 2025. Management will hold an earnings conference call on December 3, 2025 at 7:00 AM ET (8:00 PM Beijing/Hong Kong Time) to discuss results.
Dial-in numbers are provided for international, U.S., Hong Kong and mainland China participants, with separate Chinese and English interpretation lines (English is listen-only). Telephone replays will be available through December 10, 2025. A live and archived webcast will be available on the company investor relations site at http://ir.waterdrop-inc.com/.
Waterdrop Inc. (NYSE:WDH) has released its 2024 ESG Report, highlighting significant achievements in technology innovation and social impact. The company maintained its A-level ESG rating while expanding its AI capabilities with over 100 AI-related patents and investing RMB 217 million in R&D.
Key achievements include the development of "Waterdrop Guardian" LLM, the launch of 174 inclusive insurance products, and the expansion of medical crowdfunding platform which has raised RMB 67.5 billion from 470 million contributors. The company has established 167 rural medical clinics serving over 500,000 beneficiaries and reduced its greenhouse gas emissions by 33.32% year-over-year.
Waterdrop Inc. (NYSE: WDH) reported strong Q2 2025 financial results, with net operating revenue reaching RMB 838.0 million, up 23.9% year-over-year. The company's net profit surged 58.7% to RMB 140.2 million, marking its 14th consecutive profitable quarter.
The insurance business showed exceptional performance with first-year premiums increasing 80.2% to RMB 3,204.3 million. Operating profit from insurance reached RMB 170.9 million, up 39% YOY. The company enhanced its product portfolio with innovative offerings, including the industry's first Million Medical Insurance policy with no health declaration requirement.
The board approved an enhanced cash dividend of US$10.9 million, a 50% increase over the previous dividend. The company's AI initiatives, including 'KEYI.AI' and Waterdrop Guardian, have significantly improved operational efficiency and user experience.
Waterdrop Inc. (NYSE: WDH) reported strong Q2 2025 financial results, with net profit reaching RMB140.2 million (US$19.6 million), up 58.7% year-over-year. The company's insurance business showed exceptional growth with first-year premiums (FYP) of RMB3,204.3 million, increasing 80.2% year-over-year.
Key highlights include: net operating revenue of RMB838.0 million (up 23.9% YoY), significant AI integration improvements, and expansion of the E-Find Platform to 198 pharmaceutical partnerships. The Board approved an enhanced cash dividend of US$10.9 million (50% increase) and authorized a fifth annual share repurchase program of up to US$50 million.
The company completed the Shenlanbao acquisition and enhanced its medical crowdfunding platform with advanced AI capabilities, now covering 480 million donors and facilitating RMB70.0 billion in donations to 3.54 million patients.
Waterdrop (NYSE: WDH), a technology platform focused on insurance and healthcare services, has scheduled its Q2 2025 financial results announcement for September 4, 2025, before U.S. markets open.
The company will host a conference call at 8:00 AM ET on the same day to discuss the results. The call will offer both Chinese and English interpretation lines, with the English line in listen-only mode. Replay access will be available until September 11, 2025, and a webcast will be accessible through the company's investor relations website.
ONERWAY, backed by Lanchi Ventures (NYSE:LI), has secured a $10 million Series A+ funding round at a valuation approaching $200 million. The round was led by Yunqi, with participation from existing Series A investors Lanchi Ventures, Eminence Ventures, and Enlight Growth Partners.
Founded in 2017, ONERWAY has established itself as a leader in global payments infrastructure, supporting over 170 payment methods across 110 currencies in more than 60 countries. The company has maintained profitability since 2022 and plans to use the new funding to accelerate global expansion, enhance cross-border payment infrastructure, and develop new solutions including stablecoin and AI-driven products.
The company is preparing for a Series B round in 2026 to further strengthen its position in the global payments market.